FDA Inspection 1155879 — Aurobindo Pharma Ltd
The FDA completed an inspection of Aurobindo Pharma Ltd on Jul 5, 2019 in Medchal. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 5, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Medchal (India)
Additional details
Mutual Recognition Agreement (MRA)